Basal Ganglia Pathophysiology
51 – 60 of 196
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Etiology and pathogenesis of parkinson’s disease
2017) p.95-101(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?
(
- Contribution to journal › Scientific review
-
Mark
Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.
(
- Contribution to journal › Article
-
Mark
On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
(
- Contribution to journal › Letter
-
Mark
Endogenous and treatment-induced neuroplasticity in mouse models of Parkinson's disease
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
(
- Contribution to journal › Article
-
Mark
Striatal signaling in the treatment of Parkinson's disease
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
2016) p.63-75(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
2016) p.155-188(
- Chapter in Book/Report/Conference proceeding › Book chapter